When you realize just how much faster these new tools are, it becomes extremely clear why GM is embracing them. “Our FEA runs ...

Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.

From spaceflight to high-throughput studies, evidence supports greater use of organ chips, but regulatory ambiguity and ...

Four competing technologies race to solve radiation therapy's 2.5% range problem. Deep dive into radiacoustic imaging, prompt ...

Researchers from Meta and Google built AutoTTS to automatically discover optimal LLM reasoning strategies, cutting token ...

Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) ...

Key Highlights Record revenue, continued momentum: all-time high $65.3M in FY2025; strongest-ever Q1 2026, carrying into ...

Utilities, federal agencies, and the national labs have finally assembled the tools to harden the grid against an ...

Before turning to the quarter, I'd like to begin by recapping the Q1 announcements we highlighted on our last earnings call.

The following is a detailed human rights assessment of the text of the bilateral health Memoranda of Understanding between ...

IMSR: Integral Molten Salt Reactor, Terrestrial Energy's proprietary advanced nuclear reactor technology designed for modular ...

Well, good morning, everyone, and welcome to Cullinan Therapeutics Immunology Day. Today is an important milestone for Cullinan and also the way autoimmune diseases may be treated in the future. As ...